Allianzgi Health Sciences Fund Fundamentals

RAGHX Fund  USD 27.48  0.42  1.55%   
Allianzgi Health Sciences fundamentals help investors to digest information that contributes to Allianzgi Health's financial success or failures. It also enables traders to predict the movement of Allianzgi Mutual Fund. The fundamental analysis module provides a way to measure Allianzgi Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allianzgi Health mutual fund.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Allianzgi Health Sciences Mutual Fund Price To Earning Analysis

Allianzgi Health's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current Allianzgi Health Price To Earning

    
  20.87 X  
Most of Allianzgi Health's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allianzgi Health Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Based on the latest financial disclosure, Allianzgi Health Sciences has a Price To Earning of 20.87 times. This is much higher than that of the Allianz Global Investors family and significantly higher than that of the Health category. The price to earning for all United States funds is notably lower than that of the firm.

Allianzgi Health Sciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Allianzgi Health's current stock value. Our valuation model uses many indicators to compare Allianzgi Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Allianzgi Health competition to find correlations between indicators driving Allianzgi Health's intrinsic value. More Info.
Allianzgi Health Sciences is rated top fund in price to earning among similar funds. It also is rated top fund in price to book among similar funds fabricating about  0.16  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Allianzgi Health Sciences is roughly  6.38 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Allianzgi Health's earnings, one of the primary drivers of an investment's value.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module

Fund Asset Allocation for Allianzgi Health

The fund consists of 95.72% investments in stocks, with the rest of investments allocated between different money market instruments.
Asset allocation divides Allianzgi Health's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.

Allianzgi Fundamentals

About Allianzgi Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Allianzgi Health Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allianzgi Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allianzgi Health Sciences based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
The fund seeks to achieve its objective by normally investing at least 80 percent of its net assets in health sciences-related companies. The portfolio manager considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences. The fund will invest primarily in common stocks and other equity securities.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Allianzgi Mutual Fund

Allianzgi Health financial ratios help investors to determine whether Allianzgi Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allianzgi with respect to the benefits of owning Allianzgi Health security.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account